143 related articles for article (PubMed ID: 3335458)
1. Analysis of late complications after rapid hyperfractionated radiotherapy in advanced head and neck cancers.
Nguyen TD; Panis X; Froissart D; Legros M; Coninx P; Loirette M
Int J Radiat Oncol Biol Phys; 1988 Jan; 14(1):23-5. PubMed ID: 3335458
[TBL] [Abstract][Full Text] [Related]
2. Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: long-term follow-up results of RTOG 83-13.
Fu KK; Pajak TF; Marcial VA; Ortiz HG; Rotman M; Asbell SO; Coia LR; Vora NL; Byhardt R; Rubin P
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):577-88. PubMed ID: 7790242
[TBL] [Abstract][Full Text] [Related]
3. Rapid hyperfractionated radiotherapy. Clinical results in 178 advanced squamous cell carcinomas of the head and neck.
Nguyen TD; Demange L; Froissart D; Panis X; Loirette M
Cancer; 1985 Jul; 56(1):16-9. PubMed ID: 4005785
[TBL] [Abstract][Full Text] [Related]
4. Accelerated radiotherapy with delayed concomitant boost in locally advanced squamous cell carcinoma of the head and neck.
MacKenzie R; Balogh J; Choo R; Franssen E
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):589-95. PubMed ID: 10524410
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
6. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
[TBL] [Abstract][Full Text] [Related]
7. Repair halftimes estimated from observations of treatment-related morbidity after CHART or conventional radiotherapy in head and neck cancer.
Bentzen SM; Saunders MI; Dische S
Radiother Oncol; 1999 Dec; 53(3):219-26. PubMed ID: 10660202
[TBL] [Abstract][Full Text] [Related]
8. Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: results of RTOG 88-09.
Fu KK; Clery M; Ang KK; Byhardt RW; Maor MH; Beitler JJ
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):589-97. PubMed ID: 7790243
[TBL] [Abstract][Full Text] [Related]
9. Accelerated hyperfractionated irradiation with concomitant boost for stage II laryngeal cancer and locally advanced head and neck cancer.
Ishii K; Tashiro M; Hosono M; Fukuda H; Takada Y; Kondo S; Inoue Y; Iguchi H; Kusuki M; Yamane H
Acta Otolaryngol Suppl; 2004 Oct; (554):62-6. PubMed ID: 15513514
[TBL] [Abstract][Full Text] [Related]
10. Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapy.
Huguenin P; Beer KT; Allal A; Rufibach K; Friedli C; Davis JB; Pestalozzi B; Schmid S; Thöni A; Ozsahin M; Bernier J; Töpfer M; Kann R; Meier UR; Thum P; Bieri S; Notter M; Lombriser N; Glanzmann C
J Clin Oncol; 2004 Dec; 22(23):4665-73. PubMed ID: 15534360
[TBL] [Abstract][Full Text] [Related]
11. Hypofractionated radiotherapy denoted as the "Christie scheme": an effective means of palliating patients with head and neck cancers not suitable for curative treatment.
Al-mamgani A; Tans L; Van rooij PH; Noever I; Baatenburg de jong RJ; Levendag PC
Acta Oncol; 2009; 48(4):562-70. PubMed ID: 19373698
[TBL] [Abstract][Full Text] [Related]
12. [Hyperfractionated and accelerated radiotherapy in head and neck cancers: results of the EORTC trials and impact on clinical practice].
Horiot JC; Bontemps P; Begg AC; Le Fur R; Van den Bogaert W; Bolla M; N'Guyen T; Van den Weijngaert D; Bernier J; Lusinchi A; Stuschke D; Lopez Torrecilla D; Jancar B; Collette L; Van Glabbeke M; Pierart M
Bull Cancer Radiother; 1996; 83(4):314-20. PubMed ID: 9081333
[No Abstract] [Full Text] [Related]
13. Multiple fractions daily for head and neck cancer: spinal cord effects and other late results.
Crellin RP; Macmillan CH; Berridge JK; Morgan DA
Clin Oncol (R Coll Radiol); 1993; 5(3):139-42. PubMed ID: 8347535
[TBL] [Abstract][Full Text] [Related]
14. Concomitant cisplatin and hyperfractionated radiotherapy in locally advanced head and neck cancer: 10-year follow-up of a randomized phase III trial (SAKK 10/94).
Ghadjar P; Simcock M; Studer G; Allal AS; Ozsahin M; Bernier J; Töpfer M; Zimmermann F; Betz M; Glanzmann C; Aebersold DM;
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):524-31. PubMed ID: 21300466
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of mucosal acute radiation injury during accelerated-hyperfractionted split course radiotherapy (CHA-CHA) in advanced head and neck neoplasms].
Miszczyk L; Tarnawski R; Woźniak G; Maciejewski B
Otolaryngol Pol; 2002; 56(5):543-9. PubMed ID: 12523161
[TBL] [Abstract][Full Text] [Related]
16. Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicity.
Maciejewski B; Skladowski K; Pilecki B; Taylor JM; Withers RH; Miszczyk L; Zajusz A; Suwinski R
Radiother Oncol; 1996 Aug; 40(2):137-45. PubMed ID: 8884967
[TBL] [Abstract][Full Text] [Related]
17. Mature results of a randomized trial of accelerated hyperfractionated versus conventional radiotherapy in head-and-neck cancer.
Saunders MI; Rojas AM; Parmar MK; Dische S;
Int J Radiat Oncol Biol Phys; 2010 May; 77(1):3-8. PubMed ID: 20394851
[TBL] [Abstract][Full Text] [Related]
18. Predictors of severe late radiotherapy-related toxicity after hyperfractionated radiotherapy with or without concomitant cisplatin in locally advanced head and neck cancer. Secondary retrospective analysis of a randomized phase III trial (SAKK 10/94).
Ghadjar P; Simcock M; Zimmermann F; Betz M; Bodis S; Bernier J; Studer G; Aebersold DM;
Radiother Oncol; 2012 Aug; 104(2):213-8. PubMed ID: 22726581
[TBL] [Abstract][Full Text] [Related]
19. Split hyperfractionated accelerated radiation therapy and concomitant cisplatin for locally advanced head and neck carcinomas: a preliminary report.
Arias F; Domínguez MA; Illarramendi JJ; Martínez E; Tejedor M; Domínguez S; Dueñas M; Villafranca E; Elcarte F; Miquéliz S
Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):675-82. PubMed ID: 7558958
[TBL] [Abstract][Full Text] [Related]
20. Radiotherapy of advanced laryngeal cancer using three small fractions daily.
Bradley PJ; Morgan DA
Otolaryngol Head Neck Surg; 1991 Jun; 104(6):838-41. PubMed ID: 1908977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
